Elizabeth F.
Lindquist
(Liz)

Throughout the COVID-19 pandemic, Liz has represented numerous stakeholders in a wide variety of federal procurement and contracting matters, including extensive work pertaining to the U.S. government’s invocation of the Defense Production Act and use of emergency contracting procedures.  She provides strategic counsel to companies in connection with federal funding and procurement opportunities and related interactions with Congress and key federal officials, agencies, and task forces involved in pandemic response efforts, including the White House COVID-19 Task Force, the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response and Biomedical Advanced Research and Development Authority, and U.S. Department of Defense procurement authorities.

Liz is well versed in federal and state “Buy American” (i.e., domestic preference) policies and initiatives, and she develops and implements government advocacy strategies on behalf of life sciences and manufacturing companies.  Liz’s diverse client base gives her unique industry perspectives that inform her counsel on potential business opportunities and risks associated with the onshoring of essential supply chains. 

Liz graduated from the Saint Louis University School of Law in 2009, where she received a Dean’s Scholarship, a Certificate in Health Law Studies, was the Editor-in-Chief of the Saint Louis University Journal of Health Law & Policy, and was a member of the Alpha Sigma Nu Jesuit Honor Society.  Liz graduated from Williams College in 2005 with a Bachelor of Arts with Honors in Biology and History.  At Williams, she completed an Honors thesis in Biology and was an All-American softball player and Academic All-American selection.  Prior to attending law school, Liz worked as a Clinical Research Coordinator at the Hospital for Special Surgery in New York, New York.